Nucleic acid amplification testing in Indian blood banks: A review with perspectives

Background: Nucleic acid amplification testing (NAT) is restricted to a few blood banks in India since 2008. This review was directed toward understanding NAT yield in different parts of the country and prevalence in the NAT of different types of virus. Materials and Methods: English literature was...

Full description

Bibliographic Details
Main Authors: Kanjaksha Ghosh, Kanchan Mishra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
HIV
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=313;epage=318;aulast=Ghosh
id doaj-520ceb375cb541ecab08424b354ea0c8
record_format Article
spelling doaj-520ceb375cb541ecab08424b354ea0c82020-11-25T00:03:33ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292017-01-0160331331810.4103/IJPM.IJPM_361_16Nucleic acid amplification testing in Indian blood banks: A review with perspectivesKanjaksha GhoshKanchan MishraBackground: Nucleic acid amplification testing (NAT) is restricted to a few blood banks in India since 2008. This review was directed toward understanding NAT yield in different parts of the country and prevalence in the NAT of different types of virus. Materials and Methods: English literature was searched from 1990 to 2016 in PubMed, Scopus, Ind med, and Google database using properly constructed key words. Literature was collected and finally the data were synthesized. Results: NAT results from 11 publications and one personal communication showed that till date 389387 blood units have been NAT tested from various parts of the country. NAT yield varied from 1:476 to 1:4403 in various studies. Till date, 58/2550 (2%) blood banks of India are doing NAT testing but all of them have not published their results. Majority of the centers have used ID-NAT (Individual NAT) protocol and 21 blood banks are using minipool format of the test. One center has used in-house NAT testing system. In> 70% of the time, the NAT positivity with due to hepatitis B (Hep B). For individual infection, NAT yield from the pooled data showed HIV in 1:66,000, Hep C virus 1:5484 and Hep B in 1:1761 seronegative donors. Discussion and Conclusion: In view of the very high NAT yield (1:1361), NAT in some from needs to be universally applied in Indian blood banks. However, the high Hep B occult infection suggests stricter donor selection and immunization of adults for Hep B may be way forward toward ensuring the viral safety of blood components in India.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=313;epage=318;aulast=GhoshHepatitis Bhepatitis CHIVIndiaNAT testingreviewtransfusion safety
collection DOAJ
language English
format Article
sources DOAJ
author Kanjaksha Ghosh
Kanchan Mishra
spellingShingle Kanjaksha Ghosh
Kanchan Mishra
Nucleic acid amplification testing in Indian blood banks: A review with perspectives
Indian Journal of Pathology and Microbiology
Hepatitis B
hepatitis C
HIV
India
NAT testing
review
transfusion safety
author_facet Kanjaksha Ghosh
Kanchan Mishra
author_sort Kanjaksha Ghosh
title Nucleic acid amplification testing in Indian blood banks: A review with perspectives
title_short Nucleic acid amplification testing in Indian blood banks: A review with perspectives
title_full Nucleic acid amplification testing in Indian blood banks: A review with perspectives
title_fullStr Nucleic acid amplification testing in Indian blood banks: A review with perspectives
title_full_unstemmed Nucleic acid amplification testing in Indian blood banks: A review with perspectives
title_sort nucleic acid amplification testing in indian blood banks: a review with perspectives
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2017-01-01
description Background: Nucleic acid amplification testing (NAT) is restricted to a few blood banks in India since 2008. This review was directed toward understanding NAT yield in different parts of the country and prevalence in the NAT of different types of virus. Materials and Methods: English literature was searched from 1990 to 2016 in PubMed, Scopus, Ind med, and Google database using properly constructed key words. Literature was collected and finally the data were synthesized. Results: NAT results from 11 publications and one personal communication showed that till date 389387 blood units have been NAT tested from various parts of the country. NAT yield varied from 1:476 to 1:4403 in various studies. Till date, 58/2550 (2%) blood banks of India are doing NAT testing but all of them have not published their results. Majority of the centers have used ID-NAT (Individual NAT) protocol and 21 blood banks are using minipool format of the test. One center has used in-house NAT testing system. In> 70% of the time, the NAT positivity with due to hepatitis B (Hep B). For individual infection, NAT yield from the pooled data showed HIV in 1:66,000, Hep C virus 1:5484 and Hep B in 1:1761 seronegative donors. Discussion and Conclusion: In view of the very high NAT yield (1:1361), NAT in some from needs to be universally applied in Indian blood banks. However, the high Hep B occult infection suggests stricter donor selection and immunization of adults for Hep B may be way forward toward ensuring the viral safety of blood components in India.
topic Hepatitis B
hepatitis C
HIV
India
NAT testing
review
transfusion safety
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=3;spage=313;epage=318;aulast=Ghosh
work_keys_str_mv AT kanjakshaghosh nucleicacidamplificationtestinginindianbloodbanksareviewwithperspectives
AT kanchanmishra nucleicacidamplificationtestinginindianbloodbanksareviewwithperspectives
_version_ 1725433296063561728